Persephone Biosciences
PrivateLast Round
Seed
Apr 18, 2025
Est. Valuation
$2.14M
Total Funding Raised
$21.77M
Company Overview
Persephone Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Seed round in April 2025.
Persephone Biosciences is a biotechnology company that develops microbiome-based medicines and consumer health products using synthetic biology and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Persephone Biosciences Comparables
Compare Persephone Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kanvas Biosciences | 79% | |
| BiomeSense | 77% | |
| MedBiome Inc. | 77% |
For institutional investors. Book with your work email.
Persephone Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 18, 2025 | ||||
| Seed | Jul 19, 2022 | ||||
| Seed | Feb 19, 2021 | ||||
| Accelerator | Jan 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Persephone Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| ZhenFund | Seed |
| Propel Bio Partners | Seed |
| BrightEdge | Seed |
| Y Combinator | Accelerator, Seed |
| Fifty Years | Seed |
| Susa Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2022
$15M round led by First Bight Ventures and Propel Bio Partners.
- Jan 1, 2018
$150K round led by Y Combinator
For institutional investors. Book with your work email.
Persephone Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Persephone Biosciences's valuation, stock price, and market status.
Is Persephone Biosciences a public or private company?
Persephone Biosciences is a private company.
What is the current stock price of Persephone Biosciences?
Persephone Biosciences is a private company, so its shares have no public market price. Caplight tracks Persephone Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Persephone Biosciences worth (valuation)?
Persephone Biosciences's valuation is estimated at $2.1M based on funding round data.
Can I buy Persephone Biosciences stock?
Persephone Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Persephone Biosciences's last funding round?
Persephone Biosciences's most recent funding round was Seed on April 18, 2025.
Who are the main investors in Persephone Biosciences?
Key investors in Persephone Biosciences include Propel Bio Partners, First Bight Ventures.
Will Persephone Biosciences IPO soon?
No public IPO plans have been announced for Persephone Biosciences.
How can I track Persephone Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Persephone Biosciences's shares on secondary markets.